Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SPH4336 |
Synonyms | |
Therapy Description |
Limited information is currently available on SPH4336, a putative CDK4/6 inhibitor (Dec 2022). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SPH4336 | SPH 4336 | CDK4/6 Inhibitor 13 | Limited information is currently available on SPH4336, a putative CDK4/6 inhibitor (Dec 2022). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05580588 | Phase II | SPH4336 | Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas | Recruiting | USA | 0 |